Tel Aviv Sourasky Medical Center (Ichilov) - Department of Neurology

Number of service categories this organization offers.

• ✓1 service category listed

PubMed publications + ClinicalTrials.gov active trials linked to this organization.

• —0 PubMed publications
• —0 active clinical trials

How easy it is for patients and families to reach this organization.

• ✓Has website
• ✓Has phone number
• ✓Has email
• ✓Has street address
• ✓Has map coordinates

Breadth of direct support offered to patients and families.

• —In-person support groups
• —Online support groups
• —Caregiver resources in services
• —Funds or provides home care
• —Children's resources

Percentage of profile fields with information.

• ✓Name
• ✓Type
• ✓Country
• ✓State / region
• ✓Address
• ✓Phone
• ✓Email
• ✓Website
• ✓Mission

Connections to research consortia and ALS networks.

• —Part of a consortia
• —International reach
• —Publishes research
• —Maintains an ALS database
• ✓Mentions a known network (NEALS, ENCALS, TRICALS, etc.)

No community reviews yet — this dimension is excluded from the overall score.

• —No reviews yet

Contact

Mission

Israel's flagship ALS clinic — first and largest ALS clinic in Israel (operating 20+ years under Drory); globally-recognized ALS cross-ethnic epidemiology anchor; one of the world's most prolific ALS clinician-researchers. Lead: **Professor Vivian E. Drory, MD, PhD** — Israel's leading ALS clinician-researcher; 35+ years of clinical experience in neuromuscular disorders, ALS, clinical neurophysiology, electrophysiology, and EMG; studied medicine at Heidelberg Medical School Germany, trained in neurology at Tel-Aviv Medical Center, studied neuromuscular diseases and neurophysiology at Louisiana State University New Orleans; **led the first and largest ALS clinic in Israel for 20+ years**; Director of Neuromuscular Diseases Unit since 2005. First and largest ALS clinic in Israel — 20+ years under Drory Drory & Artmonov 2007 landmark cross-ethnic cohort paper — "Earlier onset and shorter survival of amyotrophic lateral sclerosis in Jewish patients of North African origin: A clue to modifying genetic factors?" (Clinical Neurology and Neurosurgery) — analyzed 374 Israeli sporadic ALS patients (211 European origin, 53 North African, 43 Oriental, 19 Balkan, 9 Arab, 7 Yemenite, 32 others); foundational global ALS cross-ancestry paper Research focus: Genetics, epidemiology, and biomarkers of motor neuron diseases — ALS, primary lateral sclerosis (PLS), adult spinal muscular atrophy (SMA) PARADIGM randomized clinical trial — Drory published on safety and efficacy of PrimeC (fixed-dose oral combination of celecoxib and ciprofloxacin targeting ALS-related mechanisms including neuroinflammation, iron homeostasis, dysregulated microRNAs)